This study evaluates the effect of two medicines on COPD (Chronic Obstructive Pulmonary
Disease) exacerbations. This study will last up to 56 weeks, and subjects will visit the
clinic 10 times. Subjects will be given breathing tests and will record their breathing
symptoms daily on diary cards. All study related medicines and medical examinations will be
provided at no cost. The two drugs used in this study have been approved by the FDA for use
in patients with COPD.
Minimum age: 40 Years.
Maximum age: N/A.
Gender(s): Both.
GSK Investigational Site, Birmingham, Alabama 35209, United States
GSK Investigational Site, Birmingham, Alabama 35294-0012, United States
GSK Investigational Site, Jasper, Alabama 35501, United States
GSK Investigational Site, Calgary, Alberta T2N 4N1, Canada
GSK Investigational Site, Glendale, Arizona 85306, United States
GSK Investigational Site, Phoenix, Arizona 85013, United States
GSK Investigational Site, Scottsdale, Arizona 85258, United States
GSK Investigational Site, Little Rock, Arkansas 72205, United States
GSK Investigational Site, Corona, California 92879, United States
GSK Investigational Site, Los Angeles, California 90095-1752, United States
GSK Investigational Site, Palmdale, California 93551, United States
GSK Investigational Site, Paramount, California 90723, United States
GSK Investigational Site, Rancho Mirage, California 92270, United States
GSK Investigational Site, Riverside, California 92506, United States
GSK Investigational Site, San Diego, California 92120, United States
GSK Investigational Site, Sepulveda, California 91343, United States
GSK Investigational Site, Stockton, California 95207, United States
GSK Investigational Site, Colorado Springs, Colorado 80907, United States
GSK Investigational Site, Denver, Colorado 80204, United States
GSK Investigational Site, Denver, Colorado 80206, United States
GSK Investigational Site, Englewood, Colorado 80113, United States
GSK Investigational Site, Wheat Ridge, Colorado 80033, United States
GSK Investigational Site, Deland, Florida 32720, United States
GSK Investigational Site, Jacksonville, Florida 32205, United States
GSK Investigational Site, Largo, Florida 33770, United States
GSK Investigational Site, North Miami Beach, Florida 33179, United States
GSK Investigational Site, Pensacola, Florida 32504, United States
GSK Investigational Site, Tampa, Florida 33613, United States
GSK Investigational Site, Coeur D'Alene, Idaho 83814, United States
GSK Investigational Site, Champaign, Illinois 61821, United States
GSK Investigational Site, Chicago, Illinois 60612, United States
GSK Investigational Site, Peoria, Illinois 61602, United States
GSK Investigational Site, Evansville, Indiana 47710, United States
GSK Investigational Site, South Bend, Indiana 46617, United States
GSK Investigational Site, Des Moines, Iowa 50309, United States
GSK Investigational Site, Lafayette, Louisiana 70503, United States
GSK Investigational Site, Slidell, Louisiana 70458, United States
GSK Investigational Site, Winnipeg, Manitoba R2K 3S8, Canada
GSK Investigational Site, Boston, Massachusetts 02118, United States
GSK Investigational Site, Worcester, Massachusetts 01608, United States
GSK Investigational Site, Kalamazoo, Michigan 49009, United States
GSK Investigational Site, Minneapolis, Minnesota 55407, United States
GSK Investigational Site, Rochester, Minnesota 55905, United States
GSK Investigational Site, Kansas City, Missouri 64108, United States
GSK Investigational Site, St. Charles, Missouri 63301, United States
GSK Investigational Site, St. Louis, Missouri 63122, United States
GSK Investigational Site, Omaha, Nebraska 68134, United States
GSK Investigational Site, Omaha, Nebraska 68105, United States
GSK Investigational Site, Cherry Hill, New Jersey 08003, United States
GSK Investigational Site, Summit, New Jersey 07091, United States
GSK Investigational Site, Albuquerque, New Mexico 87108, United States
GSK Investigational Site, Larchmont, New York 10538, United States
GSK Investigational Site, Lewistown, New York 14092, United States
GSK Investigational Site, Elizabeth City, North Carolina 27909, United States
GSK Investigational Site, Raleigh, North Carolina 27607, United States
GSK Investigational Site, Statesville, North Carolina 28625, United States
GSK Investigational Site, Cincinnati, Ohio 45219, United States
GSK Investigational Site, Cincinnati, Ohio 45231, United States
GSK Investigational Site, Cleveland, Ohio 44109, United States
GSK Investigational Site, Columbus, Ohio 43215, United States
GSK Investigational Site, Toledo, Ohio 43614-5809, United States
GSK Investigational Site, Tulsa, Oklahoma 74135, United States
GSK Investigational Site, Grimsby, Ontario L3M 1P3, Canada
GSK Investigational Site, Toronto, Ontario M5G 1N8, Canada
GSK Investigational Site, Eugene, Oregon 97401, United States
GSK Investigational Site, Medford, Oregon 97504, United States
GSK Investigational Site, Portland, Oregon 97213, United States
GSK Investigational Site, Philadelphia, Pennsylvania 19140, United States
GSK Investigational Site, Pittsburgh, Pennsylvania 15243, United States
GSK Investigational Site, Cowansville, Quebec J2K 2X9, Canada
GSK Investigational Site, La Malbaie, Quebec G5A 1W7, Canada
GSK Investigational Site, Montreal, Quebec H3T 1Y6, Canada
GSK Investigational Site, Saint Leonard, Quebec H1S 3A9, Canada
GSK Investigational Site, Sainte Jerome, Quebec J7Z 5T3, Canada
GSK Investigational Site, Sainte-Foy, Quebec G1V 4G5, Canada
GSK Investigational Site, Sherbrooke, Quebec J1H 4J6, Canada
GSK Investigational Site, Sorel, Quebec J3P 1N5, Canada
GSK Investigational Site, Cumberland, Rhode Island 02864, United States
GSK Investigational Site, Providence, Rhode Island 02906, United States
GSK Investigational Site, Charleston, South Carolina 29406-7108, United States
GSK Investigational Site, Greer, South Carolina 29651, United States
GSK Investigational Site, Simpsonville, South Carolina 29681, United States
GSK Investigational Site, Spartanburg, South Carolina 29303, United States
GSK Investigational Site, Bristol, Tennessee 37620, United States
GSK Investigational Site, Johnson City, Tennessee 37601, United States
GSK Investigational Site, Corsicana, Texas 75110, United States
GSK Investigational Site, Houston, Texas 77030, United States
GSK Investigational Site, San Antonio, Texas 78229, United States
GSK Investigational Site, Abingdon, Virginia 24210, United States
GSK Investigational Site, Charlottesville, Virginia 22908, United States
GSK Investigational Site, Newport News, Virginia 23606, United States
GSK Investigational Site, Gig Harbor, Washington 98335, United States
GSK Investigational Site, Spokane, Washington 99202, United States
GSK Investigational Site, Tacoma, Washington 98405, United States
GSK Investigational Site, Morgantown, West Virginia 26505, United States
Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir Med. 2008 Aug;102(8):1099-108. doi: 10.1016/j.rmed.2008.04.019. Epub 2008 Jul 9.